Showing 7761-7770 of 23120 results for "".
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
https://reachmd.com/programs/the-convergence/ultrasound-clement-papadacci-inserm/39926/4D ultrasound and ultrasound localization microscopy (ULM) are reshaping non-invasive imaging, allowing clinicians to visualize entire organs—down to vessels smaller than a human hair—in dynamic, real-time detail. Dr. Clément Papadacci joins Dr. Brian McDonough to share how his groundbreaking probeHow Selective Photothermolysis Was Introduced in Dermatology
https://reachmd.com/programs/modern-aesthetics-focus-on-energy-based-devices/talking-fractional-lasers-with-the-inventor/56541/Laser pioneer R. Rox Anderson, MD, FAAD, joins Modern Aesthetics March/April Guest Medical Editor Jill Waibel, FACS, FAAD, to discuss the invention of fractional lasers and the impact of that technology on the field.Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
https://reachmd.com/programs/neurofrontiers/comprehensive-care-navigating-neurobehavioral-issues-in-dmd-patients/16502/Here are some best practices for managing the 70 percent of patients with Duchenne muscular dystrophy who also have a neurobehavioral issue.Bridging Gaps with Blood-Based CRC Screening
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/bridging-gaps-blood-crc-screening/49172/Blood-based testing has the potential to expand access to colorectal cancer (CRC) screening for average-risk adults who decline colonoscopy or stool-based options. In this discussion with Ryan Quigley, Dr. Aasma Shaukat unpacks recent findings on test performance, clinical use cases, and possible reRethinking the Routine: Moving from Topicals to Systemics in Psoriasis
https://reachmd.com/programs/dermconsult/topicals-systemics-psoriasis/39680/Psoriasis management isn’t one-size-fits-all—especially when it comes to sequencing therapies. Hear Dr. Christopher Bunick outline his evidence-based approach to transitioning patients from topical to systemic treatments, including key criteria for defining topical failure, the systemic nature of psExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
https://reachmd.com/programs/neurofrontiers/examining-inebilizumab-in-generalized-myasthenia-gravis-insights-from-mint/32859/Even though the available therapeutic options for generalized myasthenia gravis (gMG) have improved outcomes, challenges like incomplete responses, treatment fatigue, and side-effect burdens remain. That's why the MINT trial, published in The New England Journal of Medicine in June 2025, explored thSaliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
https://reachmd.com/programs/clinicians-roundtable/saliva-as-a-window-into-cystic-fibrosis-metabolic-biomarkers-and-clinical-potential/35665/In a 2025 study investigating salivary metabolites as potential biomarkers in cystic fibrosis, researchers identified distinct metabolic patterns linked with key complications as well as correlations with lung function. In this AudioAbstract, Ryan Quigley discusses how a simple saliva sample could pImproving Lipid Management Through Equity-Focused Clinical Strategies
https://reachmd.com/programs/heart-matters/improving-lipid-management-through-equity-focused-clinical-strategies/37598/Despite advances in lipid-lowering therapies, disparities in hyperlipidemia diagnosis and treatment persist. Dr. Keith Ferdinand examines how social drivers of health impact access, adherence, and outcomes and explains how clinicians can help address gaps in care for underserved populations. Dr. FerDifferentiating and Diagnosing Sjögren’s-Related Dry Eye
https://reachmd.com/programs/living-rheum/differentiating-and-diagnosing-sjogrens-related-dry-eye/36338/Recognizing when dry eye symptoms are related to Sjögren’s disease is an important step in the diagnostic process for this rare autoimmune condition. Tune in to hear Dr. Michelle Hessen, an Assistant Professor of Ophthalmology at the Wilmer Eye Institute and a member of the Ocular Surface Disease anIdentifying C3G: Key Diagnostic Considerations and Challenges
https://reachmd.com/programs/frontlines-c3g/identifying-c3g-key-diagnostic-considerations-and-challenges/35487/Complement 3 glomerulopathy (C3G) presents complex diagnostic hurdles due to its rarity, clinical heterogeneity, and lack of definitive biomarkers. Tune in to hear Dr. Gates Colbert and Dr. Anuja Java discuss the need for improved biomarker development, our evolving understanding of complement dysre